C
Hold
2/24/2025Upgraded
Telix Pharmaceuticals Limited (TLPPF) was upgraded to C- from D+ on 2/24/2025 due to a large increase in the efficiency index, volatility index and growth index.
D
Sell
8/26/2024Downgrade
Telix Pharmaceuticals Limited (TLPPF) was downgraded to D+ from C- on 8/26/2024 due to a decline in the growth index, volatility index and efficiency index. Earnings per share declined from $0.0356 to $0.0222, EBIT declined 36.95% from $18.75M to $11.82M, and net income declined 34.88% from $11.82M to $7.7M.
C
Hold
8/21/2024Upgraded
Telix Pharmaceuticals Limited (TLPPF) was upgraded to C- from D+ on 8/21/2024 due to a large increase in the total return index and volatility index.
D
Sell
8/15/2024None
Telix Pharmaceuticals Limited (TLPPF) was downgraded to D+ from U on 08/15/2024.
